Search

Your search keyword '"Rappert, B."' showing total 36 results

Search Constraints

Start Over You searched for: Author "Rappert, B." Remove constraint Author: "Rappert, B."
36 results on '"Rappert, B."'

Search Results

1. Making Sense of Evidence

4. Making sense of evidence: using research training to promote organisational change.

5. What is absent from contemplative neuroscience? : Rethinking limits within the study of consciousness, experience, and meditation

7. Slow Release Isosorbide-5-Mononitrate Therapy in Angina Pectoris

8. Accountability and the Governance of Expertise : Anticipating Genetic Bioweapons, 2002-2003

18. Opening Spaces through Exhibiting Absences: Representing Secretive Pasts

19. The biopolitics of species and race in the Post-Civil War United States

20. Non-news values in science journalism

21. A country report: impact of COVID-19 lockdowns on involuntary psychiatric treatment in Austria.

22. Counting the dead and making the dead count: configuring data and accountability.

23. On conveying and not conveying expertise.

24. Why has Not There been More Research of Concern?

25. The case for addressing explosive weapons: conflict, violence and health.

26. Enhancing the protection of civilians from armed conflict: precautionary lessons.

27. Codes of conduct and biological weapons: an in-process assessment.

28. A framework for the assessment of non-lethal weapons.

29. Responsibility in the life sciences: assessing the role of professional codes.

30. Biological weapons, genetics, and social analysis: emerging responses, emerging issues--II.

31. [Health care too costly? Saving more than 10 million euros in 2 months!].

32. Coding ethical behaviour: the challenges of biological weapons.

33. Health and safety in policing: lessons from the regulation of CS sprays in the UK.

34. [Complete sinistroposition of the vena cava inferior].

35. Hemodynamics and exercise tolerance during application of transdermal systems with phasic nitroglycerin (NTG) release in comparison to 20 mg isosorbide mononitrate.

36. Comparison of pharmacokinetics and pharmacodynamics of one-week monotherapy with IS-5-N s.r. 50 or 100 mg, ISDN s.r. 120 mg or IS-5-N 2 x 20 mg in coronary heart disease patients.

Catalog

Books, media, physical & digital resources